Addressing The Top Concerns & Unmet Needs In Oncology Clinical Research: An Award-Winning Approach

The recent wave of large-scale Contract Research Organization (CRO) acquisitions, industry layoffs, reduced earnings forecasts, and divestitures over the past 18 months has significantly impacted clinical development, with no signs of abating. While major full-service CROs may suit some sponsors, many oncology trial sponsors are seeking more stability along with flexible, personalized solutions.

Worldwide Clinical Trials is dedicated to meeting this evolving industry need. As a mid-sized CRO, we strike a crucial balance between having global, full-service capabilities and the agility to create tailored solutions for complex oncology trials. Our size allows us to deliver both broad resources and specialized attention, which is essential for driving success in oncology research and achieving high performance.

To better understand the specific needs and challenges faced by oncology trial sponsors, we conducted a market needs assessment survey. We reached out to over 140 global decision-makers in clinical outsourcing from pharmaceutical and biotech companies to explore their key challenges and unmet needs. Following a review of our clinical development capabilities, 70% of respondents showed interest in learning more about Worldwide’s oncology services, highlighting our commitment to providing tailored support to our oncology sponsors.